Baker Avenue Asset Management, LP Edwards Lifesciences Corp Transaction History

Baker Avenue Asset Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$69.28 - $93.38 $1,524 - $2,054	-22 Reduced 2.99%	713 $49,000
Q2 2023 Aug 11, 2023	SELL	$81.41 - $94.33 $8,303 - $9,621	-102 Reduced 12.19%	735 $69,000
Q1 2023 May 15, 2023	BUY	$74.26 - $84.51 $10,767 - $12,253	145 Added 20.95%	837 $69,000
Q4 2022 Feb 13, 2023	BUY	$68.3 - $87.44 $47,263 - $60,508	692 New	692 $51,000
Q2 2022 Aug 03, 2022	SELL	$86.5 - $128.27 $2.24 Million - $3.33 Million	-25,940 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$101.96 - $128.34 $256,225 - $322,518	2,513 Added 10.73%	25,940 $3.05 Million
Q4 2021 Feb 11, 2022	BUY	$106.37 - $130.68 $2.49 Million - $3.06 Million	23,427 New	23,427 $3.04 Million

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Baker Avenue Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Baker Avenue Asset Management, LP with notifications on news.